Clinical Trial Update: Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations [Phase 4]

View source ↗

Summary

Phase 4 trial update focused on optimizing azithromycin prevention/treatment to reduce COPD exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Dr Ian B Wilkinson | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: RECRUITING